home
welcome note

Scientific Program

March 20th

08:00 – 09:00 Registration
09:00 – 09:45 Opening ceremony

Richard Insel (JDRF)
Michael White (JDRF)
Lior Reitblatt (JDRF Israel)
Shulamit Nuss (JDRF Israel)
Itamar Raz (D CURE Israel)
Jesse Roth (D Cure USA)
Avi Israeli (Ministry of Health)

09:45 – 10:30 Keynote lecture
Chair: Nurit Kaiser (Jerusalem)

Allen Spiegel (New York)
Strategies and vision for research on islet biology and diabetes

10:30 – 11:00 Coffee break
11:00 – 13:00 Session #1
Autoimmunity and prevention of type 1 diabetes
Chairs: Irun Cohen (Rehovot), Naim Shehadeh (Haifa)

George Eisenbarth (Denver)
The Genetic Puzzle of Type 1 Diabetes with Insulin and the MHC as Corner Pieces
Anette-Gabriele Ziegler (Munich)
Progression from autoimmunity to diabetes in man
Kevan Herold (New York)
Clinical efficacy and mechanisms of action of anti-CD3 mAb in patients with new onset Type 1 diabetes
Jay Skyler (Miami)
Prevention of Type 1 diabetes - lessons learned , prospects ahead

13:00 – 14:00 Lunch
14:00 – 15:30 Session #2
Hypoglycemia / glucose sensors / complications
Chairs: Moshe Phillip (Tel Aviv), Julio Wainstein (Tel Aviv)

Stephanie Amiel (London)
Can hypoglycaemia be avoided in diabetes?
Bruce Buckingham (Stanford)
Hypoglycemia detection and Continuous Glucose Monitoring"
Mark Cooper (Melbourne)
Interaction of haemodynamic and metabolic
factors in diabetic nephropathy : focus on oxidative stress

15:30 – 16:00 Coffee break
16:00 – 18:00 Session #3
Stem cells
Chairs: Gil Leibowitz (Jerusalem), Pnina Vardi (Tel Aviv)

Joseph Itskovitz-Eldor (Haifa)
Human embryonic stem cells: achievements and obstacles on the path towards cell-based therapy
Nissim Benvenisty (Jerusalem)
Hepatic and pancreatic differentiation of human embryonic stem cells
Yair Reisner (Rehovot)
Committed embryonic stem cells as a new source for transplantation in diabetes

Camillo Ricordi (Miami)
Challenges and opportunities in cellular therapies for diabetes



March 21st

08:00 – 09:00 Registration
09:00 – 10:30 Session #4
Beta cell development

Chairs: Michael Walker (Rehovot), Micha Rapoport (Tel Aviv)

Yuval Dor (Jerusalem)
Pancreatic beta cell regeneration
Helena Edlund (Umea)
Factors stimulating beta cell differentiation and function
Mark Magnuson (Nashville)
Multi-allelic gene targeting strategies and their application to studies of beta cell development and function

10:30 – 11:00 Coffee break
11:00 – 13:00 Session #5
New sources for surrogate beta cells
Chairs: Eddy Karnieli (Haifa), Avi Karasik (Tel Aviv)


Edward Baetge (San Diego)
Efficient production of definitive endoderm from hESCs mimics developmental events occurring during gastrulation
Marvin Gershengorn (Bethesda)

Islet precursor cells from adult human islets
Shimon Efrat (Tel Aviv)
Expansion and re-differentiation of adult human islet cells
Sarah Ferber (Tel Aviv)
Using liver to replace beta cell function
13:00 – 14:30 Lunch
14:30 – 16:00 Session #6
Beta cell death and survival
Chairs: Ben Glaser (Jerusalem) and Yehiel Zick (Rehovot)

Decio Eizirik (Brussels)
Molecular regulation of beta cell death in type 1 diabetes mellitus
Danielle Melloul (Jerusalem)
Conditional and specific NF-kB blockade protects pancreatic beta cells against diabetogenic agents
Marc Donath (Zurich)
Metabolic stress and islet inflammation

16:00 – 16:30 Coffee break
16:30 – 17:30 Closing Keynote session
Chairs: Robert Goldstein (New York), Itamar Raz (Jerusalem)

Philippe Halban (Geneva)
New frontiers in the search for a cure: the beta cell to the rescue !